Jane Street’s Juno Therapeutics, Inc. JUNO Stock Holding History

Jane Street’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-16,643	Closed	-$761K	–	5820
2017 Q4	$761K	Sell	16,643 -1,615	-9%	-$80.6K	﹤0.01%	2679
2017 Q3	$819K	Sell	18,258 -6,207	-25%	-$212K	﹤0.01%	2506
2017 Q2	$731K	Buy	+24,465	New	+$604K	﹤0.01%	2550
2017 Q1	–	Sell	-87,082	Closed	-$1.87M	–	5008
2016 Q4	$1.64M	Buy	87,082 +68,807	+377%	+$1.68M	0.01%	1503
2016 Q3	$548K	Buy	18,275 +676	+4%	+$21K	﹤0.01%	2673
2016 Q2	$676K	Sell	17,599 -21,372	-55%	-$887K	﹤0.01%	2432
2016 Q1	$1.48M	Buy	+38,971	New	+$1.36M	0.01%	1470
2015 Q4	–	Sell	-12,581	Closed	-$624K	–	4740
2015 Q3	$512K	Buy	12,581 +4,530	+56%	+$199K	﹤0.01%	2278
2015 Q2	$429K	Sell	8,051 -26,472	-77%	-$1.41M	﹤0.01%	2453
2015 Q1	$2.09M	Buy	34,523 +26,148	+312%	+$1.27M	0.02%	835
2014 Q4	$437K	Buy	+8,375	New	+$375K	﹤0.01%	1593

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Jane Street's JUNO Position: Q1 2018 in Review

Jane Street sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 16,643 shares — an estimated $761K sold.

Jane Street first reported a position in JUNO in Q4 2014 and held it in 11 quarters. The position peaked at $2.09M in Q1 2015. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Jane Street reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Jane Street sold 16,643 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $761K.
Jane Street first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 11 quarters.
Jane Street's Juno Therapeutics, Inc. position peaked at $2.09M in Q1 2015.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Jane Street's 13F filing for Q1 2018, filed 15 May 2018.